StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
HUMAN-R.BK$4.60+0.00%
Fair $4.60+0.0%

HUMAN-R.BK

Humanica Public Company Limited

Technology / Software - ApplicationThailand

$4.60

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $4.60Fund rank 39/100 · Data gapFallback financials|
SA 49/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 23% · confianza 25%

FCF escenarios

weak_data · normalized FCF $385.7M · quality 83.0/100

Data gap 39/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 88/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

49/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · HUMAN-R.BKLocal privado en este navegador · Humanica Public Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.8B

P/E

16.4x

↓

EV/EBITDA

6.1x

↓

ROE

10.4%

↑

Gross Margin

50.6%

↑

Debt/Equity

0.04

↓
52-Week Range$5
$9$9

TradingView lightweight chart

HUMAN-R.BK price, volumen y niveles de valoración

Último $9.352Periodo +9.7%
Fair value: $4.600

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+13.3%

FCF CAGR

+15.5%

FCF margin

20.9%

FCF / Net income

0.92x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.52B · net income $345.5M · FCF $317.5M

2022-FY → 2025-FY

Gross margin

50.6%+1.5% pts

Operating margin

26.7%+5.8% pts

Net margin

22.7%+6.9% pts

FCF margin

20.9%+1.2% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.52B$1.52B$1.42B$1.30B$1.05B
Net Income$345.5M$345.5M$344.0M$308.2M$164.9M
EBITDA$574.3M$574.3M$563.3M$506.4M$324.3M
EPS0.410.410.400.360.13
Gross Margin50.6%50.6%51.4%52.9%49.1%
Operating Margin26.7%26.7%27.3%26.4%20.9%
Net Margin22.7%22.7%24.2%23.7%15.8%
Balance Sheet
Debt/Equity0.040.040.030.040.06
Current Ratio2.442.44———
Cash Flow
Free Cash Flow$317.5M$317.5M$431.2M$385.7M$206.1M
Returns
ROE10.4%10.4%9.3%8.6%4.7%
Valuation
P/E16.4316.4323.3825.9888.46
EV/EBITDA6.106.1013.4215.1244.63
P/B1.171.172.202.274.28
Growth & Yield
Revenue Growth6.9%6.9%9.4%24.4%—
EPS Growth2.5%2.5%11.1%176.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-0.1%

fácil

EPS terminal req.

$0.41

Spread vs growth

2.6%

5Y implied EPS CAGR

3.8%

fácil

EPS terminal req.

$0.49

Spread vs growth

-1.3%

10Y implied EPS CAGR

6.9%

razonable

EPS terminal req.

$0.80

Spread vs growth

-4.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +0.0%

Total return

+0.0%

Start / end P/E

23.4x → 22.8x

EPS bridge

0.40 → 0.41

Residual

-0.1%

EPS growth+2.5%
Multiple rerating-2.4%
Dividend+0.0%
Residual / FX / buybacks / cross-term-0.1%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.